<DOC>
	<DOC>NCT01126281</DOC>
	<brief_summary>The aim of this study is to evaluate the effect and safety of Floseal in this preliminary prospective trial with patients undergoing acute laparoscopic cholecystectomy for acute cholecystitis</brief_summary>
	<brief_title>Efficacy and Safety of Floseal for the Haemostasis During Laparoscopic Cholecystectomy in Acute Cholecystitis (GLA)</brief_title>
	<detailed_description />
	<mesh_term>Cholecystitis</mesh_term>
	<mesh_term>Acalculous Cholecystitis</mesh_term>
	<mesh_term>Cholecystitis, Acute</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<criteria>Patients aged 18 65 Clinical (pain, fever &gt; 37.5 Â°C, WBC &gt; 10.000 / microL), and ultrasound evidence of cholecystitis Surgical indication for laparoscopic cholecystectomy ASA class IIII Informed consent &lt;72 hours from onset of symptoms Informed consent refusal Choledocholithiasis Pre surgical generalized peritonitis (clinical evaluation) ASA class &gt; III Peripheral artery disease Active or past history of malignant systemic disease Pregnant or lactating females Known allergy to components Floseal including bovine allergy (bovine gelatin) Known drug or alcohol abuse Patients with known diabetes, chronic renal disease and other metabolic diseases Patients in chronic cortisone treatment more than 2 years before surgery Patients on chronic use of platelet inhibitors such as Aspirin, Plavix, NSAID's etc.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>